Journals / İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi / 2020 / Sayı: 10

Investigation of GST Isoenzymes, Multi-Drug Resistance Proteins and Apoptotic Effect in MCF-7 Human Breast Cancer Cell Line Before and After Doxorubicin Treatment

MCF-7 İnsan Meme Kanseri Hücre Soyunda Doksorubisin Öncesi ve Sonrası GST İzozimlerinin, İlaç Dirençlilik Proteinlerinin ve Apoptotik Etkisinin Araştırılması

Pages
1–18
Publication Date
2020-04-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this context, the alkylating functionality at developing resistance to the cancer drug has been reported that increased level intracellular glutathione and glutathione S- conjugates have a role in cancer chemoresistance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In the treatment of cancer, one of the problems encountered in clinical therapy of tumor cells had developed resistance against chemotherapy patients.
📊
Key Findings & Data:The ABC (ATP-binding cassette) protein that helps drugs outside the cell membrane and has shown resistance of tumor cells to these drugs, is one of the most important members of transporter proteins.
💡
Conclusion & Impact:In this context, the alkylating functionality at developing resistance to the cancer drug has been reported that increased level intracellular glutathione and glutathione S- conjugates have a role in cancer chemoresistance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Meme Kanseri · GST · MDR

Abstract

Aim: In the treatment of cancer, one of the problems encountered in clinical therapy of tumor cells had developed resistance against chemotherapy patients. The ABC (ATP-binding cassette) protein that helps drugs outside the cell membrane and has shown resistance of tumor cells to these drugs, is one of the most important members of transporter proteins. Besides that drug resistance protein is known to be effective on other intracellular proteins. In this context, the alkylating functionality at developing resistance to the cancer drug has been reported that increased level intracellular glutathione and glutathione S- conjugates have a role in cancer chemoresistance.

Özet

Amaç: Kanser hastalığının tedavisinde karşılaşılan klinik sorunlardan biri hastalara uygulanan kemoterapiye karşı tümör hücrelerinin geliştirdiği dirençtir. Tümör hücrelerinin ilaçlara karşı gösterdiği direncin asıl kaynaklarından biri, ilaçların hücre dışına atılmasını sağlayan membran proteinlerinin en önemli üyelerinden ABC (ATP-binding cassette) taşıyıcı proteinleridir. İlaç dirençlilik proteinlerinin yanında diğer hücre içi proteinlerinde etkin olabileceği bilinmektedir. Bu bağlamda, alkilleyici özellikteki kanser ilaçlarına gelişen dirençte, hücre içi glutatyon ve glutatyon S- konjugatlarının seviyelerinin artmasının rolünün olduğu bildirilmiştir. Bu çalışmada, Michigan Cancer Foundation-7 (MCF-7) meme kanseri hücre hattında Glutatyon S-transferaz (GST) izozimlerinin çoklu ilaç direnç mekanizmasındaki bazı önemli proteinlerin doksorubisin uygulamasıyla ilişkilerinin incelenmesi amaçlanmıştır.

🔖

Cite This Article

KOÇDOĞAN, A. K., OĞUZTÜZÜN, S., ŞİMŞEK, G. G., TÜRK, M. (2020). Investigation of GST Isoenzymes, Multi-Drug Resistance Proteins and Apoptotic Effect in MCF-7 Human Breast Cancer Cell Line Before and After Doxorubicin Treatment. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 10, 1–18. https://ajindex.com/articles/675758

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tozkoparan B, Peri Aytaç S. Kanser kemoterapisinde terapötik hedef olarak glutatyon S-transferazlar. Hacettepe Üniversitesi, Eczacılık Fakültesi Dergisi. 2007;7(2):139-164. Dünyada Kanser İstatistikleri. Türk Kanser Araştırma ve Savaş Kurumu (TKASKD).http://turkkanser.org.tr. Yayınlanma tarihi 1995. Erişim tarihi 20.09.2019. Onur H. Tıbbi Onkoloji Kitabı. Ankara Üniversitesi Tıp Fakültesi: Antıp Yayınları; 2005.
  2. Gate L, Tew KD. Glutathione S-transferases as emerging targets, Expert Opin Ther. Targets. 2001;5(4):477-489. Szakács G, Paterson, JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219-34.
  3. Stavrovskaya AA, Stromskaya TP. Transport proteins of the ABC familya and multidrug resistance of tumor cells. Biochemistry (Mosc). 2008;73(5):592-604.
  4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2009;59(4):225-249. doi: 10.3322/caac.20006. Tuncer M. Significance of cancer in Turkey, the burden of disease and cancer control policies. Cancer Control in Turkey, Ankara,
  5. Onur Press, Health Ministry Publication. 2008:74;5-9.
  6. Marie JP, Legrand O. Drug resistance in acute leukaemia and reversion. Turk J Med Sci. 2003;33:271-279.
  7. Turgut S, Yaren A, Kursunluoğlu R, Turgut G. MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res. 2007:38;539-544.
  8. Eaton DL, Bammler TK. Concise Review of glutathione s-transferase and their significance to toxicology. Toxicological Sciences. 1999;49:156-164.
  9. Oguztuzun S, Abu-Hijleh A, Coban T, et al. GST isoenzymes in matched normal and neoplastic breast tissue. Neoplasma. 2011;58(4):304-310.
  10. Buller Al, Clapper M, Smith T, Tew KD Glutathione S-trasnferase in nitrogen mustard-resistance and-sensitive. Molecular Pharmacology. 1987;31(6):575-578.
  11. Oguri T, Fujimara Y, Katoh O, et al. Glutathione S-transferase gene expression and platinum drug exposure in human lung cancer. Cancer Letters. 2000;156:93-99.
  12. Ban N, Takahashi Y, Takayama T, et al. Transfection of glutathione S-transferase (GST)-pi anti sense complementary DNA increase sthesensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalanandetoposide. Cancer Res. 1996;56:3577-3582.
  13. Goto S, Ieda T, Cho S, Oka M, Kohno S, Kondo T. Over expression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free RadicRes. 1999;31:549-558.
  14. Fengxi S, Xiaogu H, Weijuan J, Chang G, Erwei S, Peter H. Glutathi